Loading…
Loading…
Cardinal Health, Inc. (CAH) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
In the latest trading session, Cardinal Health (CAH) closed at $240.49, marking a -2.71% move from the previous day.
Technology is becoming a bigger part of CAH's strategy, linking distribution, specialty services and logistics through digital workflows.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cardinal Health's generic volumes, profitable brand-to-generic conversions and Red Oak program continue to support Pharma profits.
NBIX's Crenessity gains rapid traction in CAH, with sales soaring and low patient penetration leaving room for growth.
Connor Clark and Lunn Investment Management Ltd. bought a new position in shares of Cardinal Health, Inc. (NYSE: CAH) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 3,554 shares of the company's stock, valued at approximately $844,000. Other large investors also